Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00459524 · ClinicalTrials.gov registry record
Quality of Life of Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 104
- Enrollment target
NCT00459524: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00459524 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 104 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00459524 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 104 participants
- Enrollment target
Study Summary
Primary Objectives: * To compare the neuropsychiatric (NP) and neurocognitive (NC) symptoms and assess the quality of life (QOL) in older patients (age \> 18) with acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (MDS) receiving different therapies, chemotherapy (Clofarabine + ara-C) or targeted therapies (PKC412 + low-dose ara-C, or R115777 + low-dose ara-C, or decitabine, or STI + low-dose ara-C). * To determine whether there is a correlation between the number of packed red blood cell (PRBC) transfusions and cognitive scores and/or QOL.
Interventions
- BEHAVIORAL Questionnaire
- BEHAVIORAL Neurocognitive Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2004-04 |
| Est. Completion | 2009-03 |
What the finished NCT00459524 record still lists
NCT00459524 is an observational study that tracks outcomes without assigning an intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Questionnaire is the first listed.
NCT00459524 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00459524 about?
NCT00459524 is a clinical study titled "Quality of Life of Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)". Primary Objectives: * To compare the neuropsychiatric (NP) and neurocognitive (NC) symptoms and assess the quality of life (QOL) in older patients (age \> 18) with acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (MDS) receiving different therapies, chemotherapy (Clofarabine +...
What is the current status of trial NCT00459524?
This trial is currently completed. The enrollment target is 104 participants. The study started on 2004-04. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00459524?
The interventions under investigation include: Questionnaire (BEHAVIORAL), Neurocognitive Testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT00459524?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia